See more : Ørsted A/S (ORSTED.CO) Income Statement Analysis – Financial Results
Complete financial analysis of Sangui Biotech International, Inc. (SGBI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sangui Biotech International, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Henderson Land Development Company Limited (0012.HK) Income Statement Analysis – Financial Results
- Hangzhou First Applied Material Co., Ltd. (603806.SS) Income Statement Analysis – Financial Results
- Clarocity Corporation (CLRYF) Income Statement Analysis – Financial Results
- Magnetic Resources NL (MAUCA.AX) Income Statement Analysis – Financial Results
- Amiyaki Tei Co., Ltd. (2753.T) Income Statement Analysis – Financial Results
Sangui Biotech International, Inc. (SGBI)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.sanguibiotech.com
About Sangui Biotech International, Inc.
Sangui Biotech International, Inc., through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. The company's artificial oxygen carriers provide oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds. It also offers nano formulations for the regeneration of skin, including skin moisturization and enhanced skin elasticity; Chitoskin wound pads for supporting wound healing; and Hemospray wound spray, a medical product that is used for the healing of chronic wounds. The company sells its wound spray products under the Granulox brand name primarily in Europe and Mexico; and cosmetics products through internet shop. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 93.04K | 69.19K | 65.59K | 28.92K | 88.00K | 77.15K | 67.65K | 48.01K | 127.47K | 133.47K | 105.49K | 14.95K | 5.56K | 17.98K | 31.53K | 207.18K | 372.02K | 137.26K | 45.21K | 23.23K | 0.00 | 571.74K | 567.01K | 429.40K |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 62.00 | 693.00 | 293.00 | 532.00 | 793.00 | 10.69K | 3.34K | 6.60K | 7.95K | 17.14K | 45.72K | 256.81K | 118.02K | 44.05K | 16.44K | 0.00 | 364.18K | 395.28K | -1.29M |
| Gross Profit | 93.04K | 69.19K | 65.59K | 28.92K | 88.00K | 77.09K | 66.96K | 47.72K | 126.94K | 132.68K | 94.80K | 11.61K | -1.04K | 10.03K | 14.39K | 161.45K | 115.21K | 19.24K | 1.16K | 6.79K | 0.00 | 207.56K | 171.73K | 1.72M |
| Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 99.92% | 98.98% | 99.39% | 99.58% | 99.41% | 89.86% | 77.68% | -18.66% | 55.78% | 45.64% | 77.93% | 30.97% | 14.02% | 2.57% | 29.23% | 0.00% | 36.30% | 30.29% | 400.39% |
| Research & Development | 4.87K | 8.57K | 8.27K | 8.31K | 27.23K | 23.00K | 16.53K | 37.78K | 204.99K | 543.07K | 65.01K | 104.41K | 313.67K | 111.57K | 195.58K | 213.61K | 155.89K | 111.61K | 426.83K | 886.96K | 846.66K | 1.29M | 946.96K | 183.88K |
| General & Administrative | 175.89K | 199.30K | 207.64K | 200.79K | 398.41K | 262.13K | 321.40K | 316.91K | 674.29K | 906.41K | 1.27M | 3.62M | 1.43M | 917.59K | 596.73K | 663.95K | 665.88K | 609.95K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 45.83K | 53.93K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 175.89K | 199.30K | 207.64K | 200.79K | 398.41K | 262.13K | 367.23K | 370.84K | 674.29K | 906.41K | 1.27M | 3.62M | 1.43M | 917.59K | 596.73K | 663.95K | 665.88K | 609.95K | 480.67K | 671.38K | 0.00 | 3.03M | 2.58M | 2.90M |
| Other Expenses | 356.00 | 770.00 | 816.00 | 1.21K | 0.00 | 0.00 | 367.23K | 370.84K | 674.29K | 906.88K | 1.27M | 3.62M | 1.43M | 940.37K | 601.37K | 667.91K | 687.42K | 646.83K | 547.56K | -903.18K | -3.20M | 3.88M | 3.17M | 4.62M |
| Operating Expenses | 181.12K | 208.64K | 216.72K | 210.31K | 425.64K | 285.14K | 383.76K | 408.62K | 879.27K | 1.45M | 1.34M | 3.72M | 1.74M | 1.05M | 796.95K | 881.52K | 843.31K | 758.43K | 974.39K | -16.22K | -2.35M | 5.17M | 4.12M | 4.81M |
| Cost & Expenses | 181.12K | 208.64K | 216.72K | 210.31K | 425.64K | 285.20K | 384.45K | 408.91K | 879.80K | 1.45M | 1.35M | 3.73M | 1.75M | 1.06M | 814.09K | 927.25K | 1.10M | 876.45K | 1.02M | 222.00 | 2.35M | 5.54M | 4.51M | 3.52M |
| Interest Income | 20.61K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 36.00 | 49.00 | 25.42K | 0.00 | 0.00 | 0.00 | 11.70K | 3.50K | 90.00 | 96.00 | 704.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 19.36K | 17.99K | 14.10K | 11.69K | 8.31K | 9.21K | 69.84K | 6.11K | 8.68K | 4.57K | 225.00 | 0.00 | 0.00 | 1.55M | 137.59K | 23.68K | 12.09K | 3.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 356.00 | 17.25K | 816.00 | 1.21K | 171.86K | 14.54K | 17.03K | 8.47K | 468.00 | 468.00 | 865.00 | 692.00 | 1.23K | 1.93K | 3.31K | 3.96K | 21.29K | 36.88K | 66.89K | 86.62K | 309.02K | 855.75K | 591.02K | 1.72M |
| EBITDA | -87.73K | -20.92K | -150.32K | -180.19K | -330.83K | -208.05K | -316.80K | -360.90K | -752.34K | -1.58M | -2.27M | -3.71M | -1.60M | -1.03M | -774.62K | -1.08M | -685.02K | -702.32K | -906.34K | 109.63K | -2.00M | -4.11M | -3.35M | -1.36M |
| EBITDA Ratio | -94.29% | -176.61% | -229.20% | -623.15% | -383.67% | -269.66% | -468.27% | -751.74% | -590.18% | -1,170.72% | -1,154.33% | -24,817.39% | -34,010.14% | -5,785.06% | -2,474.39% | -345.65% | -189.90% | -526.03% | -2,604.95% | 372.92% | 0.00% | -735.17% | -598.13% | -363.80% |
| Operating Income | -88.08K | -139.45K | -151.14K | -181.39K | -337.64K | -208.05K | -316.80K | -360.90K | -752.34K | -1.32M | -1.24M | -3.71M | -1.74M | -1.04M | -782.56K | -720.07K | -728.10K | -739.19K | -973.23K | 23.01K | -2.35M | -4.96M | -3.94M | -3.09M |
| Operating Income Ratio | -94.67% | -201.54% | -230.45% | -627.34% | -383.67% | -269.66% | -468.27% | -751.74% | -590.21% | -986.95% | -1,179.24% | -24,822.02% | -31,361.91% | -5,795.79% | -2,482.27% | -347.56% | -195.72% | -538.55% | -2,152.59% | 99.04% | 0.00% | -868.18% | -695.51% | -718.99% |
| Total Other Income/Expenses | -59.63K | 76.10K | -52.57K | -17.13K | -4.88K | -7.76K | -12.81K | -85.46K | -6.07K | -254.43K | -1.02M | 165.55K | 217.25K | -7.24K | -1.54M | -126.31K | 6.54K | 7.71K | 271.41K | 23.01K | 111.41K | 95.29K | 38.89K | 198.62K |
| Income Before Tax | -147.71K | -63.34K | -203.71K | -198.53K | -342.51K | -215.80K | -329.61K | -446.36K | -758.41K | -1.57M | -2.26M | -3.54M | -1.60M | -1.04M | -2.32M | -854.16K | -721.56K | -731.49K | -701.82K | 46.01K | -2.24M | -4.87M | -3.90M | -2.89M |
| Income Before Tax Ratio | -158.76% | -91.55% | -310.60% | -686.58% | -389.22% | -279.71% | -487.20% | -929.74% | -594.97% | -1,177.58% | -2,145.94% | -23,713.09% | -28,844.56% | -5,791.82% | -7,346.10% | -412.29% | -193.96% | -532.93% | -1,552.28% | 198.09% | 0.00% | -851.51% | -688.65% | -672.74% |
| Income Tax Expense | 0.00 | -80.14K | 32.27K | 20.22K | -25.75K | -13.99K | -20.63K | -24.09K | -53.71K | -245.75K | -1.02M | 166.00K | 140.04K | 715.00 | 1.55M | -461.00 | 30.21K | 31.79K | 274.91K | 23.01K | 111.41K | 95.29K | 38.89K | 198.62K |
| Net Income | -147.72K | 16.79K | -235.98K | -218.74K | -316.77K | -201.81K | -308.98K | -422.27K | -704.70K | -1.43M | -2.10M | -3.49M | -1.53M | -972.89K | -2.32M | -854.16K | -721.56K | -731.49K | -704.61K | -1.57M | -2.31M | -4.80M | -3.63M | -2.75M |
| Net Income Ratio | -158.77% | 24.27% | -359.80% | -756.51% | -359.96% | -261.57% | -456.71% | -879.57% | -552.84% | -1,070.48% | -1,986.50% | -23,357.27% | -27,456.73% | -5,411.84% | -7,346.10% | -412.29% | -193.96% | -532.93% | -1,558.46% | -6,778.53% | 0.00% | -839.10% | -639.83% | -640.40% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 | -0.03 | -0.02 | -0.01 | -0.04 | -0.02 | -0.01 | -0.02 | -0.02 | -0.04 | -0.06 | -0.12 | -0.09 | -0.08 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 | -0.03 | -0.02 | -0.01 | -0.04 | -0.02 | -0.01 | -0.02 | -0.02 | -0.04 | -0.06 | -0.12 | -0.09 | -0.08 |
| Weighted Avg Shares Out | 210.13M | 208.60M | 204.19M | 201.75M | 197.13M | 188.20M | 178.46M | 154.81M | 145.64M | 137.03M | 128.55M | 116.69M | 93.92M | 75.89M | 59.28M | 50.00M | 50.00M | 48.75M | 44.31M | 40.66M | 40.66M | 40.62M | 40.51M | 34.48M |
| Weighted Avg Shares Out (Dil) | 209.96M | 208.60M | 204.19M | 201.75M | 197.13M | 188.20M | 178.46M | 154.81M | 145.64M | 137.03M | 128.55M | 116.69M | 93.92M | 75.89M | 59.28M | 50.00M | 50.00M | 48.75M | 44.31M | 40.66M | 40.66M | 40.62M | 40.51M | 34.48M |
Source: https://incomestatements.info
Category: Stock Reports